Cooperation between distinct viral variants promotes growth of h3n2 influenza in cell culture

eLife

Volumn 5, Issue MARCH2016, 2016, Pages

  Xue, Katherine S ^a,b   Hooper, Kathryn A ^a,b   Ollodart, Anja R ^a,b   Dingens, Adam S ^a,b   Bloom, Jesse D ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OSELTAMIVIR; SIALIDASE; MUTANT PROTEIN; NA PROTEIN, INFLUENZA A VIRUS; VIRAL PROTEIN;

ARTICLE; BINDING AFFINITY; CELL CULTURE; COOPERATION; DYNAMICS; GENE FREQUENCY; GENE MUTATION; GENOTYPING TECHNIQUE; HUMAN; INFLUENZA A (H3N2); NONHUMAN; POLYMERASE CHAIN REACTION; PYROSEQUENCING; REVERSE GENETICS; RNA VIRUS; ANIMAL; DOG; ENZYMOLOGY; GENETIC VARIATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; INFLUENZA A VIRUS (H3N2); MDCK CELL LINE; MISSENSE MUTATION; VIRUS LOAD;

ANIMALS; DOGS; GENETIC VARIATION; INFLUENZA A VIRUS, H3N2 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; MUTANT PROTEINS; MUTATION, MISSENSE; NEURAMINIDASE; VIRAL LOAD; VIRAL PROTEINS;

EID: 84962243492     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.13974     Document Type: Article

References (37)

1. Andino R, Domingo E. 2015. Viral quasispecies. Virology 479-480:46–51. doi: 10.1016/j.virol.2015.03.022
2. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D. 2008. The influenza virus resource at the national center for biotechnology information. Journal of Virology 82:596–601. doi: 10.1128/JVI.02005-07
3. Bloom JD, Gong LI, Baltimore D. 2010. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science 328:1272–1275. doi: 10.1126/science.1187816
4. Bogner P, Capua I, Cox NJ, Lipman DJ. 2006. A global initiative on sharing avian flu data. Nature 442:981. doi: 10.1038/442981a
5. Bordería AV, Isakov O, Moratorio G, Henningsson R, Agüera-González S, Organtini L, Gnädig NF, Blanc H, Alcover A, Hafenstein S, Fontes M, Shomron N, Vignuzzi M. 2015. Group selection and contribution of minority variants during virus adaptation determines virus fitness and phenotype. PLOS Pathogens 11:e1004838. Public Library of Science: e1004838. doi: 10.1371/journal.ppat.1004838
6. Cao L, Wu C, Shi H, Gong Z, Zhang E, Wang H, Zhao K, Liu S, Li S, Gao X, Wang Y, Pei R, Lu M, Chen X. 2014. Coexistence of hepatitis b virus quasispecies enhances viral replication and the ability to induce host antibody and cellular immune responses. Journal of Virology 88:8656–8666. doi: 10.1128/JVI.01123-14
7. Chambers BS, Li Y, Hodinka RL, Hensley SE. 2014. Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. Journal of Virology 88: 10986–10989. doi: 10.1128/JVI.01077-14
8. Ciota AT, Ehrbar DJ, Van Slyke GA, Willsey GG, Kramer LD. 2012. Cooperative interactions in the west nile virus mutant swarm. BMC Evolutionary Biology 12:58. doi: 10.1186/1471-2148-12-58
9. Deyde VM, Okomo-Adhiambo M, Sheu TG, Wallis TR, Fry A, Dharan N, Klimov AI, Gubareva LV. 2009. Pyrosequencing as a tool to detect molecular markers of resistance to neuraminidase inhibitors in seasonal influenza a viruses. Antiviral Research 81:16–24. doi: 10.1016/j.antiviral.2008.08.008
10. Dutta RN, Rouzine IM, Smith SD, Wilke CO, Novella IS. 2008. Rapid adaptive amplification of preexisting variation in an RNA virus. Journal of Virology 82:4354–4362. doi: 10.1128/JVI.02446-07
11. Eigen M. 1971. Selforganization of matter and the evolution of biological macromolecules. Die Naturwissenschaften 58:465–523 http://www.ncbi.nlm.nih.gov/pubmed/4942363. doi: 10.1007/BF00623322
12. Gulati U, Wu W, Gulati S, Kumari K, Waner JL, Air GM. 2005. Mismatched hemagglutinin and neuraminidase specificities in recent human H3N2 influenza viruses. Virology 339:12–20. doi: 10.1016/j.virol.2005.05.009
13. Gulati S, Smith DF, Cummings RD, Couch RB, Griesemer SB, George K, Webster RG, Air GM. 2013. Human H3N2 influenza viruses isolated from 1968 to 2012 show varying preference for receptor substructures with no apparent consequences for disease or spread. PLoS ONE 8:e66325. doi: 10.1371/journal.pone.0066325
14. Hoffmann E, Neumann G, Kawaoka Y, Hobom G, Webster RG. 2000. A DNA transfection system for generation of influenza a virus from eight plasmids. Proceedings of the National Academy of Sciences of the United States of America 97:6108–6113. doi: 10.1073/pnas.100133697
15. Holland J, Spindler K, Horodyski F, Grabau E, Nichol S, VandePol S. 1982. Rapid evolution of RNA genomes. Science 215:1577–1585. doi: 10.1126/science.7041255
16. Holmes EC. 2010. The RNA virus quasispecies: fact or fiction? Journal of Molecular Biology 400:271–273. doi: 10.1016/j.jmb.2010.05.032
17. Hooper KA, Bloom JD. 2013. A mutant influenza virus that uses an N1 neuraminidase as the receptor-binding protein. Journal of Virology 87:12531–12540. doi: 10.1128/JVI.01889-13
18. Ke R, Aaskov J, Holmes EC, Lloyd-Smith JO. 2013. Phylodynamic analysis of the emergence and epidemiological impact of transmissible defective dengue viruses. PLoS Pathogens 9:e1003193. doi: 10.1371/journal.ppat.1003193
19. Lauring AS, Andino R. 2010. Quasispecies theory and the behavior of RNA viruses. PLoS Pathogens 6:e1001005. doi: 10.1371/journal.ppat.1001005
20. Lee HK, Tang JW-T, Kong DH-L, Loh TP, Chiang DK-L, Lam TT-Y, Koay ES-C. 2013. Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage. PLoS ONE 8:e79252. doi: 10.1371/journal.pone.0079252
21. Lin YP, Gregory V, Collins P, Kloess J, Wharton S, Cattle N, Lackenby A, Daniels R, Hay A. 2010. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? Journal of Virology 84:6769–6781. doi: 10.1128/JVI.00458-10
22. Lin YP, Xiong X, Wharton SA, Martin SR, Coombs PJ, Vachieri SG, Christodoulou E, Walker PA, Liu J, Skehel JJ, Gamblin SJ, Hay AJ, Daniels RS, McCauley JW. 2012. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin. Proceedings of the National Academy of Sciences of the United States of America 109:21474–21479. doi: 10.1073/pnas.1218841110
23. Liu C, Air GM. 1993. Selection and characterization of a neuraminidase-minus mutant of influenza virus and its rescue by cloned neuraminidase genes. Virology 194:403–407. doi: 10.1006/viro.1993.1276
24. McKimm-Breschkin J, Trivedi T, Hampson A, Hay A, Klimov A, Tashiro M, Hayden F, Zambon M. 2003. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrobial Agents and Chemotherapy 47:2264–2272. doi: 10.1128/AAC.47.7.2264-2272.2003
25. Mishin VP, Sleeman K, Levine M, Carney PJ, Stevens J, Gubareva LV. 2014. The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses. Antiviral Research 101:93–96. doi: 10.1016/j.antiviral.2013.11.001
26. Mohr PG, Deng Y-M, McKimm-Breschkin JL. 2015. The neuraminidases of MDCK grown human influenza A (H3N2) viruses isolated since 1994 can demonstrate receptor binding. Virology Journal 12:67. doi: 10.1186/s12985-015-0295-3
27. Nájera I, Holguín A, Quiñones-Mateu ME, Muñoz-Fernández MA, Nájera R, López-Galíndez C, Domingo E. 1995. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy. Journal of Virology 69:23–31. http://jvi.asm.org/content/69/1/23.short
28. Neverov AD, Kryazhimskiy S, Plotkin JB, Bazykin GA. 2015. Coordinated evolution of influenza a surface proteins. PLOS Genetics 11:e1005404. doi: 10.1371/journal.pgen.1005404
29. Okomo-Adhiambo M, Nguyen HT, Sleeman K, Sheu TG, Deyde VM, Garten RJ, Xu X, Shaw MW, Klimov AI, Gubareva LV. 2010. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Research 85:381–388. doi: 10.1016/j.antiviral.2009.11.005
30. Pfeiffer JK, Kirkegaard K. 2005. Increased fidelity reduces poliovirus fitness and virulence under selective pressure in mice. PLoS Pathogens 1:e11. doi: 10.1371/journal.ppat.0010011
31. Rice P, Longden I, Bleasby A. 2000. EMBOSS: the european molecular biology open software suite. Trends in Genetics 16:276–277. doi: 10.1016/S0168-9525(00)02024-2
32. Shirogane Y, Watanabe S, Yanagi Y. 2012. Cooperation between different RNA virus genomes produces a new phenotype. Nature Communications 3:1235. doi: 10.1038/ncomms2252
33. Tamura D, Nguyen HT, Sleeman K, Levine M, Mishin VP, Yang H, Guo Z, Okomo-Adhiambo M, Xu X, Stevens J, Gubareva LV. 2013. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment. Antimicrobial Agents and Chemotherapy 57:6141–6146. doi: 10.1128/AAC.01364-13
34. Vignuzzi M, Stone JK, Arnold JJ, Cameron CE, Andino R. 2006. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 439:344–348. doi: 10.1038/nature04388
35. Wagner R, Matrosovich M, Klenk H-D. 2002. Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Reviews in Medical Virology 12:159–166. doi: 10.1002/rmv.352
36. Wilke CO, Reissig DD, Novella IS. 2004. Replication at periodically changing multiplicity of infection promotes stable coexistence of competing viral populations. Evolution 58:900–905. doi: 10.1111/j.0014-3820.2004.tb00422.x
37. Zhu X, McBride R, Nycholat CM, Yu W, Paulson JC, Wilson IA. 2012. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic acid receptors. Journal of Virology 86:13371–13383. doi: 10.1128/JVI.01426-12